Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Metagenomi TherapeuticsMGX | Open-market sale | 06/05 | 06/10 | 2,884 sh | $1.30 | $3,749.2 | −1.4% | |
Jian IrishSEE REMARKS | Metagenomi TherapeuticsMGX | Open-market sale | 06/05 | 06/10 | 3,737 sh | $1.30 | $4,858.1 | −1.0% |
Matthew WeinSEE REMARKS | Metagenomi TherapeuticsMGX | Open-market sale | 06/05 | 06/10 | 558 sh | $1.30 | $725.4 | −0.4% |
Metagenomi TherapeuticsMGX | Open-market sale | 03/05 | 03/09 | 1,581 sh | $1.60 | $2,529.6 | −0.8% | |
Jian IrishCEO | Metagenomi TherapeuticsMGX | Open-market sale | 03/05 | 03/09 | 1,607 sh | $1.60 | $2,571.2 | −0.5% |
Matthew WeinSEE REMARKS | Metagenomi TherapeuticsMGX | Open-market sale | 03/05 | 03/09 | 482 sh | $1.60 | $771.2 | −0.4% |
Metagenomi TherapeuticsMGX | Open-market sale | 25/12/05 | 25/12/08 | 1,576 sh | $1.77 | $2,789.52 | −0.8% | |
Jian IrishCEO | Metagenomi TherapeuticsMGX | Open-market sale | 25/12/05 | 25/12/08 | 1,602 sh | $1.77 | $2,835.54 | −0.3% |
Brian C. ThomasDirector | Metagenomi TherapeuticsMGX | Open-market sale | 25/12/05 | 25/12/08 | 3,830 sh | $1.77 | $6,779.1 | −0.2% |
Matthew WeinSEE REMARKS | Metagenomi TherapeuticsMGX | Open-market sale | 25/12/05 | 25/12/08 | 199 sh | $1.77 | $352.23 | −0.2% |
Metagenomi TherapeuticsMGX | Open-market sale | 25/09/05 | 25/12/01 | 1,576 sh | $1.81 | $2,852.56 | −2.2% | |
Jian IrishCEO | Metagenomi TherapeuticsMGX | Open-market sale | 25/09/05 | 25/12/01 | 1,602 sh | $1.81 | $2,899.62 | −0.5% |
Brian C. ThomasDirector | Metagenomi TherapeuticsMGX | Open-market sale | 25/09/05 | 25/12/01 | 2,701 sh | $1.81 | $4,888.81 | −0.1% |
Matthew WeinSEE REMARKS | Metagenomi TherapeuticsMGX | Open-market sale | 25/09/05 | 25/12/01 | 199 sh | $1.81 | $360.19 | −1.0% |
Sarah B. NoonbergChief Medical Officer | Metagenomi TherapeuticsMGX | Open-market sale | 25/06/06 | 25/06/09 | 5,239 sh | $1.75 | $9,168.25 | −4.6% |
Metagenomi TherapeuticsMGX | Open-market sale | 25/06/06 | 25/06/09 | 1,576 sh | $1.75 | $2,758 | −2.1% | |
Jian IrishSEE REMARKS | Metagenomi TherapeuticsMGX | Open-market sale | 25/06/06 | 25/06/09 | 6,390 sh | $1.75 | $11,182.5 | −2.0% |
Metagenomi TherapeuticsMGX | Open-market sale | 25/06/06 | 25/06/09 | 10,785 sh | $1.75 | $18,873.75 | −0.4% | |
Matthew WeinSEE REMARKS | Metagenomi TherapeuticsMGX | Open-market sale | 25/06/06 | 25/06/09 | 199 sh | $1.75 | $348.25 | −1.2% |
Metagenomi TherapeuticsMGX | Open-market sale | 25/03/05 | 25/03/07 | 1,808 sh | $1.87 | $3,380.96 | −2.9% |